You are here

Global

U.S and WHO Urge U.S. Companies to Share Covid Vaccine Technology

Pressure is growing on American drug companies — particularly Moderna, the upstart biotech firm that developed its coronavirus vaccine with billions of dollars in taxpayer money — to share their formulas with manufacturers in nations that desperately need more shots.

Problem, Solution, SitRep, or ?: 

Breakthrough COVID-19 cases expected to become more common in coming months

A breakthrough case of COVID-19 occurs when a person contracts COVID-19 at least two full weeks after the final dose of the vaccine. The Centers for Disease Control and Prevention tracks only breakthrough cases that result in hospitalization or death, as these incidences are both serious and very rare.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Pages

Subscribe to Global
howdy folks